You have reached the guest article limit.
Unlock more of the IIPLA newsroom by signing in with SSO or joining as a member.
Moleculin Biotech Expands Global Patent Portfolio with Hong Kong Approval for Annamycin Reconstitution Method Moleculin Biotech has secured a key patent in Hong Kong covering its proprietary method of reconstituting liposomal Annamycin, extending its intellectual property protection through 2040. This milestone enhances the com... Read the full IIPLA article: https://iipla.org/news/moleculin-biotech-expands-global-patent-portfolio-with-hong-kong-approval-for-annamycin-reconstitution-method